Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
by
Yang, Xin
, Li, Linli
, Zhang, Liting
, Luo, Xinling
, Tian, Chenyu
, Yang, Shengyong
, Zou, Jun
, Yang, Wei
, Wu, Chengyong
, Wang, Yifei
, Xu, Haixing
, Li, Yueshan
, Yang, Ruicheng
, Wang, Falu
in
13
/ 14
/ 38
/ 49
/ 631/154/309/2144
/ 631/154/309/2420
/ 631/1647/2258/1266
/ 631/45/275
/ Biological activity
/ Deep Learning
/ Drug Design
/ Drug development
/ Drug Discovery
/ Humanities and Social Sciences
/ Inflammation
/ Inhibitors
/ Lead compounds
/ multidisciplinary
/ Necroptosis
/ Neural networks
/ Neural Networks, Computer
/ Recurrent neural networks
/ Retrieval
/ Scaffolds
/ Science
/ Science (multidisciplinary)
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
by
Yang, Xin
, Li, Linli
, Zhang, Liting
, Luo, Xinling
, Tian, Chenyu
, Yang, Shengyong
, Zou, Jun
, Yang, Wei
, Wu, Chengyong
, Wang, Yifei
, Xu, Haixing
, Li, Yueshan
, Yang, Ruicheng
, Wang, Falu
in
13
/ 14
/ 38
/ 49
/ 631/154/309/2144
/ 631/154/309/2420
/ 631/1647/2258/1266
/ 631/45/275
/ Biological activity
/ Deep Learning
/ Drug Design
/ Drug development
/ Drug Discovery
/ Humanities and Social Sciences
/ Inflammation
/ Inhibitors
/ Lead compounds
/ multidisciplinary
/ Necroptosis
/ Neural networks
/ Neural Networks, Computer
/ Recurrent neural networks
/ Retrieval
/ Scaffolds
/ Science
/ Science (multidisciplinary)
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
by
Yang, Xin
, Li, Linli
, Zhang, Liting
, Luo, Xinling
, Tian, Chenyu
, Yang, Shengyong
, Zou, Jun
, Yang, Wei
, Wu, Chengyong
, Wang, Yifei
, Xu, Haixing
, Li, Yueshan
, Yang, Ruicheng
, Wang, Falu
in
13
/ 14
/ 38
/ 49
/ 631/154/309/2144
/ 631/154/309/2420
/ 631/1647/2258/1266
/ 631/45/275
/ Biological activity
/ Deep Learning
/ Drug Design
/ Drug development
/ Drug Discovery
/ Humanities and Social Sciences
/ Inflammation
/ Inhibitors
/ Lead compounds
/ multidisciplinary
/ Necroptosis
/ Neural networks
/ Neural Networks, Computer
/ Recurrent neural networks
/ Retrieval
/ Scaffolds
/ Science
/ Science (multidisciplinary)
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
Journal Article
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor
2022
Request Book From Autostore
and Choose the Collection Method
Overview
The retrieval of hit/lead compounds with novel scaffolds during early drug development is an important but challenging task. Various generative models have been proposed to create drug-like molecules. However, the capacity of these generative models to design wet-lab-validated and target-specific molecules with novel scaffolds has hardly been verified. We herein propose a generative deep learning (GDL) model, a distribution-learning conditional recurrent neural network (cRNN), to generate tailor-made virtual compound libraries for given biological targets. The GDL model is then applied to RIPK1. Virtual screening against the generated tailor-made compound library and subsequent bioactivity evaluation lead to the discovery of a potent and selective RIPK1 inhibitor with a previously unreported scaffold, RI-962. This compound displays potent in vitro activity in protecting cells from necroptosis, and good in vivo efficacy in two inflammatory models. Collectively, the findings prove the capacity of our GDL model in generating hit/lead compounds with unreported scaffolds, highlighting a great potential of deep learning in drug discovery.
Retrieval of a new starting active compound with a novel scaffold during early drug development is an important but challenging task. Here, the authors propose a generative deep learning model and by applying this model they discover a potent and highly selective RIPK1 inhibitor with a previously unreported scaffold.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
This website uses cookies to ensure you get the best experience on our website.